Regeneron Pharmaceuticals announced Thursday that it has begun clinical trials on a potential treatment for coronavirus using antibodies that the body produces to fight the disease.…
Regeneron Pharmaceuticals announced Thursday that it has begun clinical trials on a potential treatment for coronavirus using antibodies that the body produces to fight the disease.
Regeneron is testing a cocktail of two antibodies to both treat and prevent coronavirus, developed using people who have recovered from coronavirus as well as genetically modified mice.
The company did not give a firm timeline for its work, but these antibody cocktails could be ready sooner than a vaccine.
